Cargando…

The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a common hematological malignant disease, characterized by malignant hematopoietic stem cell proliferation in the bone marrow (BM); clinically, it mainly manifests clinically mainly by as pathological hematopoiesis, hemocytopenia, and high-risk transformation to acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Likun, Zhang, Lei, Guo, Yixuan, Xu, Xintong, Liu, Zhaoyun, Yan, Zhenyu, Fu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767949/ https://www.ncbi.nlm.nih.gov/pubmed/36569863 http://dx.doi.org/10.3389/fimmu.2022.1078421

Ejemplares similares

Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes
por: Liu, Zhaoyun, et al.
Publicado: (2022)

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations
por: Refaie, Ayman F., et al.
Publicado: (2021)

Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy
por: Liu, Zhaoyun, et al.
Publicado: (2022)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
por: Li, Lijuan, et al.
Publicado: (2022)

Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
por: Mattiucci, Domenico, et al.
Publicado: (2018)

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
por: Perico, Norberto, et al.
Publicado: (2018)

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
por: Zhaoyun, Liu, et al.
Publicado: (2021)

Iron Overload Impairs Bone Marrow Mesenchymal Stromal Cells from Higher-Risk MDS Patients by Regulating the ROS-Related Wnt/β-Catenin Pathway
por: Huang, Lei, et al.
Publicado: (2020)

Immunological Derangement in Hypocellular Myelodysplastic Syndromes
por: Serio, B, et al.
Publicado: (2014)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
por: Rathnayake, A. J. I. S., et al.
Publicado: (2016)

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes
por: Fei, Cheng-Ming, et al.
Publicado: (2018)

The value of serum IL-4 to predict the survival of MDS patients
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes
por: Meng, Fanqiao, et al.
Publicado: (2020)

The Mesenchymal Niche in Myelodysplastic Syndromes
por: Friedrich, Chloé, et al.
Publicado: (2022)

Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis
por: Meng, Fanqiao, et al.
Publicado: (2020)

Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma
por: Choi, Hayoung, et al.
Publicado: (2020)

Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications
por: Hirosue, Sachiko, et al.
Publicado: (2015)

Mesenchymal Stromal Cells for Transplant Tolerance
por: Podestà, Manuel Alfredo, et al.
Publicado: (2019)

Editorial: Revisiting immunological roles for bone marrow stromal cell antigen-1; an entero-neuro-immune regulator
por: Funaro, Ada, et al.
Publicado: (2023)

Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells
por: Yi, Qiuyun, et al.
Publicado: (2023)

The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification
por: Peng, Xiaohuan, et al.
Publicado: (2022)

Roles of Carotenoids in Invertebrate Immunology
por: Tan, Karsoon, et al.
Publicado: (2020)

Sonic Hedgehog Produced by Bone Marrow-Derived Mesenchymal Stromal Cells Supports Cell Survival in Myelodysplastic Syndrome
por: Zou, Jixue, et al.
Publicado: (2015)

The Immunology of Takotsubo Syndrome
por: Lim, Kenji Rowel Q., et al.
Publicado: (2023)

Immunological characterization of stroke-heart syndrome and identification of inflammatory therapeutic targets
por: Zheng, Junyi, et al.
Publicado: (2023)

The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
por: He, Haiping, et al.
Publicado: (2021)

Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review
por: Vegivinti, Charan Thej Reddy, et al.
Publicado: (2023)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
por: Paracatu, Luana Chiquetto, et al.
Publicado: (2020)

Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
por: Simoni, Yannick, et al.
Publicado: (2022)

Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands
por: Hackel, Alexander, et al.
Publicado: (2023)

Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches
por: Hazrati, Ali, et al.
Publicado: (2023)

The Immunology of Macrophage Activation Syndrome
por: Crayne, Courtney B., et al.
Publicado: (2019)

Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes
por: Abbas, Hussein A., et al.
Publicado: (2021)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?
por: Plock, Jan A., et al.
Publicado: (2013)

The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
por: Weiss, Daniel J., et al.
Publicado: (2019)

Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
por: Podestà, Manuel Alfredo, et al.
Publicado: (2021)

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell
por: Hansen, Stine Bangsgaard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4puhd6482aaethv77atg2oj6o